Five Prime Therapeutics is a biotechnology company that aims to develop protein therapeutics for treating cancer and inflammatory diseases. Its leading product candidate, FPA008, is an antibody that blocks colony stimulating factor-1 receptor and is currently in Phase Ib clinical trials for rheumatoid arthritis. The company also has plans to develop FPA008 for pigmented villonodular synovitis and multiple cancers in combination with nivolumab. Overall, Five Prime Therapeutics is focused on advancing its clinical pipeline and improving patient outcomes.
Five Prime Therapeutics Inc's ticker is FPRX
The company's shares trade on the NASDAQ stock exchange
They are based in San Francisco, California
There are 51-200 employees working at Five Prime Therapeutics Inc
It is http://www.fiveprime.com/
Five Prime Therapeutics Inc is in the Healthcare sector
Five Prime Therapeutics Inc is in the Biotechnology industry
The following five companies are Five Prime Therapeutics Inc's industry peers: